Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06843720 · ClinicalTrials.gov registry record · NA
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
A NA study of HR-HPV Testing, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 7,100
- Enrollment target
- 1
- Study location
NCT06843720 is a NA study of HR-HPV Testing that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 7,100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06843720, a NA study of HR-HPV Testing, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 7,100 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn about the attitudes toward implementing self-collection among healthcare providers and staff, participants, and other stakeholders; and to inform the development of patient education and provider training materials to aid in the implementation of self-collection in clinical settings.
Conditions Studied
Interventions
- BEHAVIORAL HR-HPV Testing
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,100 participants |
| Start Date | 2025-02-17 |
| Est. Completion | 2031-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06843720
The ClinicalTrials.gov registry entry for NCT06843720 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 7,100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HR-HPV Testing appearing as the primary indexed condition, and to 1 intervention - of which HR-HPV Testing is the first listed.
NCT06843720 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06843720 about?
NCT06843720 is a clinical study titled "Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems". To learn about the attitudes toward implementing self-collection among healthcare providers and staff, participants, and other stakeholders; and to inform the development of patient education and provider training materials to aid in the implementation of self-collection in clinical settings.
What is the current status of trial NCT06843720?
This trial is currently recruiting. It is a NA study. The enrollment target is 7,100 participants. The study started on 2025-02-17. Estimated completion is 2031-03-31.
What conditions does trial NCT06843720 study?
This clinical trial studies the following conditions: HR-HPV Testing.
What interventions are being tested in trial NCT06843720?
The interventions under investigation include: HR-HPV Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT06843720?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06843720 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.